Summary Stage 2018: Biliary Other

Summary Stage 2018

Notes

**Biliary Other** 8000-8700, 8720-8790 C248, C249 C248 Overlapping lesion of biliary tract (neoplasms involving both intrahepatic and extrahepatic bile ducts) C249 Biliary tract, NOS **Note 1:** The following sources were used in the development of this chapter * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx **Note 2:** See the following chapters for the listed histologies * 8710-8714, 8800-8934, 8940-9138, 9141-9582: *Soft Tissue* * 8935-8936: *GIST* * 9140: *Kaposi Sarcoma* * 9700-9701: *Mycosis Fungoides* **Note 3:** Summary Stage is the only applicable staging system for this site/histology/schema.

NAACCR Item

NAACCR #764
SS2018 Description
0 In situ, intraepithelial, noninvasive
1 Localized only (localized, NOS) - Confined to bile duct, NOS - Lamina propria - Mucosa, NOS - Muscularis propria - Submucosa (superficial invasion)
2 Regional by direct extension only - Ampulla of Vater - Beyond wall of bile duct - Duodenum - Gallbladder + Unilateral branches of the right or left hepatic artery OR portal vein - Invasion of/through serosa - Liver, less than or equal to 2 cm or UNKNOWN - Omentum (greater or lesser) - Pancreas - Perimuscular connective tissue - Small intestine
3 Regional lymph node(s) involved only - Celiac - Cystic duct (node of Calot) - Node of foramen of Winslow (epiploic) (omental) - Pancreaticoduodenal - Pericholedochal (common bile duct) - Periduodenal - Peripancreatic (near head of pancreas only) - Porta hepatis (portal) (periportal) (hilar) - Superior mesenteric - Regional lymph node(s), NOS + Lymph node(s), NOS
4 Regional by BOTH direct extension AND regional lymph node(s) involved - Codes (2) + (3)
7 Distant site(s)/lymph node(s) involved - Distant site(s) (including further contiguous extension) + Abdominal wall + Colon + Common hepatic artery + Cystic artery/vein + Hepatic artery, NOS + Liver greater than 2 cm + Portal vein or its branches bilaterally + Portal vein, NOS + Stomach - Distant lymph node(s), NOS + Para-aortic + Peripancreatic (along body and tail of pancreas only) - Distant metastasis, NOS + Carcinomatosis + Distant metastasis WITH or WITHOUT distant lymph node(s)
9 Unknown if extension or metastasis
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998 (2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001. (3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05.** American Joint Committee on Cancer (Chicago, IL)